Wyeth Pharmaceutical Division of Wyeth Holdings LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 401 N Middletown Rd, Pearl River, New York (NY) 10965, United States (USA)
- Operations here
- analysisapi manufacturemanufacturepack
- FDA identifiers
- FEI 2410662 · DUNS 054065909
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-12-17
- VAIDrug Quality Assurance2024-08-28
- VAIDrug Quality Assurance2022-04-13
- VAIVaccines and Allergenic Products2012-10-24
- NAIBioresearch Monitoring2009-07-01
Drugs this plant is listed as making
5 distinct drugs across 9 products name this site in their FDA label.
- desvenlafaxine succinateWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- gemtuzumab ozogamicinWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- inotuzumab ozogamicinWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- sirolimusMylan Pharmaceuticals Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.